Cargando…
Continuous morphine infusion for end-stage lung cancer patients
End-stage cancer patients frequently receive continuous morphine infusion (CMI) to alleviate the various symptoms associated with cancer progression or adverse events; however, there have been a limited number of studies concerning such patients. We conducted a retrospective analysis of 79 end-stage...
Autores principales: | KIM, YOUNG HAK, OKUDA, CHIYUKI, SAKAMORI, YUICHI, MASAGO, KATSUHIRO, TOGASHI, YOSUKE, MISHIMA, MICHIAKI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576204/ https://www.ncbi.nlm.nih.gov/pubmed/23426526 http://dx.doi.org/10.3892/ol.2012.1101 |
Ejemplares similares
-
Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer
por: TOGASHI, YOSUKE, et al.
Publicado: (2013) -
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
por: Togashi, Yosuke, et al.
Publicado: (2011) -
Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer
por: Fukuhara, Akiko, et al.
Publicado: (2010) -
Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation
por: Masago, Katsuhiro, et al.
Publicado: (2010) -
Disease Flare after Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-Positive Lung Cancer
por: Kuriyama, Yuka, et al.
Publicado: (2013)